Risk factors for eosinophilic esophagitis

Clinical and Experimental Allergy

Volumn 44, Issue 8, 2014, Pages 1012-1019

  Philpott, H ^a,c   Nandurkar, S ^a   Royce, S G ^b   Thien, F ^a   Gibson, P R ^c  

^a BOX HILL HOSPITAL   (Australia)

^b MONASH UNIVERSITY   (Australia)

^c ALFRED HOSPITAL   (Australia)

Author keywords

Allergy; Antigen; Eosinophil; Esophagus; Remodelling

Indexed keywords

CORTICOSTEROID; EOTAXIN 3; FILAGGRIN; FOOD ANTIGEN; IMMUNOGLOBULIN E; MITOCHONDRIAL DNA; PROTON PUMP INHIBITOR; RELAXIN; THYMIC STROMAL LYMPHOPOIETIN; ALLERGEN;

ADULTHOOD; AGE; ARTICLE; ATOPY; CAUCASIAN; CHILDHOOD; CLIMATE; DIET THERAPY; EOSINOPHILIC ESOPHAGITIS; ESOPHAGUS BIOPSY; FIBROSIS; FOOD ALLERGY; GENDER; GENETICS; IMMUNOLOGICAL TOLERANCE; INCIDENCE; MIGRATION; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RISK FACTOR; SEX RATIO; SINGLE NUCLEOTIDE POLYMORPHISM; ADVERSE EFFECTS; FEMALE; FOOD; GENETIC PREDISPOSITION; HUMAN; IMMUNOLOGY; MALE; MICROFLORA; SEX DIFFERENCE;

AGE FACTORS; ALLERGENS; EOSINOPHILIC ESOPHAGITIS; FEMALE; FOOD; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MICROBIOTA; RISK FACTORS; SEX FACTORS;

EID: 84904659685     PISSN: 09547894     EISSN: 13652222     Source Type: Journal    
DOI: 10.1111/cea.12363     Document Type: Article

References (75)

1. Dellon ES, Gonsalves N, Hirano I, Furuta GT, Liacouras CA, Katzka DA. ACG clinical guideline: evidenced based approach to the diagnosis and management of esophageal eosinophilia and eosinophilic esophagitis (EoE). Am J Gastroenterol 2013; 108:679-92.quiz 93.
2. Attwood SE, Smyrk TC, Demeester TR, Jones JB. Esophageal eosinophilia with dysphagia. A distinct clinicopathologic syndrome. Dig Dis Sci 1993; 38:109-16.
3. Aguilera-Aguirre L, Bacsi A, Saavedra-Molina A, Kurosky A, Sur S, Boldogh I. Mitochondrial dysfunction increases allergic airway inflammation. J Immunol 2009; 183:5379-87.
4. Corona G, Rastrelli G, Vignozzi L, Mannucci E, Maggi M. Testosterone, cardiovascular disease and the metabolic syndrome. Best Pract Res Clin Endocrinol Metab 2011; 25:337-53.
5. Vignozzi L, Filippi S, Morelli A et al. Testosterone/estradiol ratio regulates NO-induced bladder relaxation and responsiveness to PDE5 inhibitors. J Sex Med 2012; 9:3028-40.
6. Sherrill JD, Gao PS, Stucke EM et al. Variants of thymic stromal lymphopoietin and its receptor associate with eosinophilic esophagitis. J Allergy Clin Immunol 2010; 126:160-5.e3.
7. Prasad GA, Alexander JA, Schleck CD et al. Epidemiology of eosinophilic esophagitis over three decades in Olmsted County, Minnesota. Clin Gastroenterol Hepatol 2009; 7:1055-61.
8. Alexander ES, Martin LJ, Abonia JP et al. Twin Shared Environment Increa-ses Risk of Eosinophilic Esophagitis in Families. J Allergy Clin Immunol 2012; 129:AB245.
9. Caldwell JM, Blanchard C, Collins MH et al. Glucocorticoid-regulated genes in eosinophilic esophagitis: a role for FKBP51. J Allergy Clin Immunol 2010; 125:879-88.e8.
10. Wen T, Stucke EM, Grotjan TM et al. Molecular diagnosis of eosinophilic esop-hagitis by gene expression profiling. Gastroenterology 2013; 145:1289-99.
11. De Benedetto A, Qualia CM, Baroody FM, Beck LA. Filaggrin expression in oral, nasal, and esophageal mucosa. J Invest Dermatol 2008; 128:1594-7.
12. Vitellas KM, Bennett WF, Bova JG, Johnston JC, Caldwell JH, Mayle JE. Idiopathic eosinophilic esophagitis. Radiology 1993; 186:789-93.
13. Levine MS, Saul SH. Idiopathic eosinophilic esophagitis: how common is it? Radiology 1993; 186:631-2.
14. van Rhijn BD, Verheij J, Smout AJ, Bredenoord AJ. Rapidly increasing incidence of eosinophilic esophagitis in a large cohort. Neurogastroenterol Motil 2013; 25:47-52.e5.
15. Hruz P, Straumann A, Bussmann C et al. Escalating incidence of eosinophilic esophagitis: a 20-year prospective, population-based study in Olten County, Switzerland. J Allergy Clin Immunol 2011; 128:1349-50.e5.
16. Mahesh VN, Holloway RH, Nguyen NQ. Changing epidemiology of food bolus impaction: is eosinophilic esophagitis to blame? J Gastroenterol Hepatol 2013; 28:963-6.
17. Lack G. Update on risk factors for food allergy. J Allergy Clin Immunol 2012; 129:1187-97.
18. Matysiak-Budnik T, Heyman M. Food allergy and Helicobacter pylori. J Pediatr Gastroenterol Nutr 2002; 34:5-12.
19. Okada H, Kuhn C, Feillet H, Bach JF. The 'hygiene hypothesis' for autoimmune and allergic diseases: an update. Clin Exp Immunol 2010; 160:1-9.
20. Merwat SN, Spechler SJ. Might the use of acid-suppressive medications predispose to the development of eosinophilic esophagitis? Am J Gastroenterol 2009; 104:1897-902.
21. Roth-Walter F, Berin MC, Arnaboldi P et al. Pasteurization of milk proteins promotes allergic sensitization by enhancing uptake through Peyer's patches. Allergy 2008; 63:882-90.
22. Franciosi JP, Tam V, Liacouras CA, Spergel JM. A case-control study of sociodemographic and geographic characteristics of 335 children with eosinophilic esophagitis. Clin Gastroenterol Hepatol 2009; 7:415-9.
23. Cherian S, Smith NM, Forbes DA. Rapidly increasing prevalence of eosinophilic oesophagitis in Western Australia. Arch Dis Child 2006; 91:1000-4.
24. Gonsalves N, Yang GY, Doerfler B, Ritz S, Ditto AM, Hirano I. Elimination diet effectively treats eosinophilic esophagitis in adults; food reintroduction identifies causative factors. Gastroenterology 2012; 142:1451-9.e1; quiz e14-5.
25. Straumann A. The natural history and complications of eosinophilic esophagitis. Gastrointestinal Endoscopy Clinics of North America 2008; 18:99-118; ix. PubMed PMID: 18061105.
26. Menard-Katcher P, Marks KL, Liacouras CA, Spergel JM, Yang YX, Falk GW. The natural history of eosinophilic oesophagitis in the transition from childhood to adulthood. Aliment Pharmacol Ther 2013; 37:114-21.
27. Silverberg JI, Hanifin JM. Adult eczema prevalence and associations with asthma and other health and demographic factors: a US population-based study. J Allergy Clin Immunol 2013; 132:1132-8.
28. Siroux V, Curt F, Oryszczyn MP, Maccario J, Kauffmann F. Role of gender and hormone-related events on IgE, atopy, and eosinophils in the Epidemiological Study on the Genetics and Environment of Asthma, bronchial hyperresponsiveness and atopy. J Allergy Clin Immunol 2004; 114:491-8.
29. Noti M, Wojno ED, Kim BS et al. Thymic stromal lymphopoietin-elicited basophil responses promote eosinophilic esophagitis. Nat Med 2013; 19:1005-13.
30. Royce SG, Sedjahtera A, Samuel CS, Tang ML. Combination therapy with relaxin and methylprednisolone augments the effects of either treatment alone in inhibiting subepithelial fibrosis in an experimental model of allergic airways disease. Clin Sci 2013; 124:41-51.
31. Samuel CS, Hewitson TD, Unemori EN, Tang ML. Drugs of the future: the hormone relaxin. Cell Mol Life Sci 2007; 64:1539-57.
32. Lekgabe ED, Royce SG, Hewitson TD et al. The effects of relaxin and estrogen deficiency on collagen deposition and hypertrophy of nonreproductive organs. Endocrinology 2006; 147:5575-83.
33. Moawad FJ, Veerappan GR, Lake JM et al. Correlation between eosinophilic oesophagitis and aeroallergens. Aliment Pharmacol Ther 2010; 31:509-15.
34. Cheng E, Zhang X, Huo X et al. Omeprazole blocks eotaxin-3 expression by oesophageal squamous cells from patie-nts with eosinophilic oesophagitis and GORD. Gut 2013; 62:824-32.
35. Sherrill JD, Rothenberg ME. Genetic dissection of eosinophilic esophagitis provides insight into disease pathogenesis and treatment strategies. J Allergy Clin Immunol 2011; 128:23-32; quiz 3-4.
36. Aceves SS, Newbury RO, Chen D et al. Resolution of remodeling in eosinophilic esophagitis correlates with epithelial response to topical corticosteroids. Allergy 2010; 65:109-16.
37. Dellon ES. The pathogenesis of eosinophilic esophagitis: beyond the eosinophil. Dig Dis Sci 2013; 58:1445-8.
38. Mulder DJ, Justinich CJ. Understanding eosinophilic esophagitis: the cellular and molecular mechanisms of an emerging disease. Mucosal Immunol 2011; 4:139-47.
39. Boyce JA, Assa'ad A, Burks AW et al. Guidelines for the Diagnosis and Management of Food Allergy in the United States: summary of the NIAID-Sponsored Expert Panel Report. J Allergy Clin Immunol 2010; 126:1105-18.
40. Untersmayr E, Jensen-Jarolim E. The role of protein digestibility and antacids on food allergy outcomes. J Allergy Clin Immunol 2008; 121:1301-8; quiz 9-10.
41. Miehlke S, Alpan O, Schroder S, Straumann A. Induction of eosinophilic esophagitis by sublingual pollen immunotherapy. Case Rep Gastroenterol. 2013; 7:363-8.
42. Wolf WA, Jerath MR, Dellon ES. De-novo onset of eosinophilic esophagitis after large volume allergen exposures. J Gastrointestin Liver Dis 2013; 22:205-8.
43. Ramirez RM, Jacobs RL. Eosinophilic esophagitis treated with immunotherapy to dust mites. J Allergy Clin Immunol 2013; 132:503-4.
44. Mishra A, Hogan SP, Brandt EB, Rothenberg ME. An etiological role for aeroallergens and eosinophils in experimental esophagitis. J Clin Invest 2001; 107:83-90.
45. Almansa C, Krishna M, Buchner AM et al. Seasonal distribution in newly diagnosed cases of eosinophilic esophagitis in adults. Am J Gastroenterol 2009; 104:828-33.
46. Hamish Philpott PG, Sanjay Nandurkar RB, Andrew Finch RG, Eaton L, Srinivasan A. Significant heterogeneity in management of food bolus obstruction and divergence from ideal management: a large, multicentre study. J Gastroenterol Hepatol 2012; 27:132.
47. Braunstahl GJ, Kleinjan A, Overbeek SE, Prins JB, Hoogsteden HC, Fokkens WJ. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med 2000; 161:2051-7.
48. de Groot EP, Nijkamp A, Duiverman EJ, Brand PL. Allergic rhinitis is associated with poor asthma control in children with asthma. Thorax 2012; 67:582-7.
49. Hurrell JM, Genta RM, Dellon ES. Prevalence of esophageal eosinophilia varies by climate zone in the United States. Am J Gastroenterol 2012; 107:698-706.
50. Mullins RJ, Clark S, Camargo CA Jr. Regional variation in epinephrine autoinjector prescriptions in Australia: more evidence for the vitamin D-anaphylaxis hypothesis. Ann Allergy Asthma Immunol 2009; 103:488-95.
51. Oktaria V, Dharmage SC, Burgess JA et al. Association between latitude and allergic diseases: a longitudinal study from childhood to middle-age. Ann Allergy Asthma Immunol 2013; 110:80-5.e1.
52. Leung R. Asthma, allergy and atopy in South-east Asian immigrants in Australia. Aust N Z J Med 1994; 24:255-7.
53. Boguniewicz M, Leung DY. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 2011; 242:233-46.
54. Blanchard C, Stucke EM, Burwinkel K et al. Coordinate interaction between IL-13 and epithelial differentiation cluster genes in eosinophilic esophagitis. J Immunol 2010; 184:4033-41.
55. De Benedetto A, Rafaels NM, McGirt LY et al. Tight junction defects in patients with atopic dermatitis. J Allergy Clin Immunol 2011; 127:773-86.e1-7.
56. Sherrill JD, Kc K, Wu D et al. Desmoglein-1 regulates esophageal epithelial barrier function and immune responses in eosinophilic esophagitis. Mucosal Immunology 2014; 7:718-729.
57. Tobey NA, Carson JL, Alkiek RA, Orlando RC. Dilated intercellular spa-ces: a morphological feature of acid reflux-damaged human esophageal epithelium. Gastroenterology 1996; 111:1200-5.
58. Molina-Infante J, Ferrando-Lamana L, Ripoll C et al. Esophageal eosinophilic infiltration responds to proton pump inhibition in most adults. Clin Gastroenterol Hepatol 2011; 9:110-7.
59. Spechler SJ, Genta RM, Souza RF. Thoughts on the complex relationship between gastroesophageal reflux disease and eosinophilic esophagitis. Am J Gastroenterol 2007; 102:1301-6.
60. Amir I, Konikoff FM, Oppenheim M, Gophna U, Half EE. Gastric microbiota is altered in oesophagitis and Barrett's oesophagus and further modified by proton pump inhibitors. Environ Micro-biol 2013; Sep 20. doi: 10.1111/1462-2920.12285. [Epub ahead of print].
61. Blackett KL, Siddhi SS, Cleary S et al. Oesophageal bacterial biofilm changes in gastro-oesophageal reflux disease, Barrett's and oesophageal carcinoma: association or causality? Aliment Pharmacol Ther 2013; 37:1084-92.
62. Jakobsson HE, Abrahamsson TR, Jenmalm MC et al. Decreased gut microbiota diversity, delayed Bacteroidetes colonisation and reduced Th1 responses in infants delivered by Caesarean section. Gut 2014; 63:559-66.
63. Simon D, Bieber T. Systemic therapy for atopic dermatitis. Allergy 2014; 69:46-55.
64. Schroeder S, Robinson ZD, Masterson JC et al. Esophageal human beta-defensin expression in eosinophilic esophagitis. Pediatr Res 2013; 73:647-54.
65. Dellon ES, Kim HP, Sperry SL, Rybnicek DA, Woosley JT, Shaheen NJ. A phenotypic analysis shows that eosinophilic esophagitis is a progressive fibrostenotic disease. Gastrointest Endosc 2014; 79:577-85.
66. Aceves SS, Ackerman SJ. Relationships between eosinophilic inflammation, tissue remodeling, and fibrosis in eosinophilic esophagitis. Immunol Allergy Clin North Am 2009; 29:197-211, xiii-xiv.
67. Hirano I, Moy N, Heckman MG, Thomas CS, Gonsalves N, Achem SR. Endoscopic assessment of the oesophageal features of eosinophilic oesophagitis: validation of a novel classification and grading system. Gut 2013; 62:489-95.
68. Abonia JP, Franciosi JP, Rothenberg ME. TGF-beta1: mediator of a feedback loop in eosinophilic esophagitis-or should we really say mastocytic esophagitis? J Allergy Clin Immunol 2010; 126:1205-7.
69. Schoepfer AM, Safroneeva E, Bussmann C et al. Delay in diagnosis of eosinophilic esophagitis increases risk for stricture formation, in a time-dependent manner. Gastroenterology 2013; 145:1230-6.e1-2.
70. Aceves SS, Chen D, Newbury RO, Dohil R, Bastian JF, Broide DH. Mast cells infiltrate the esophageal smooth muscle in patients with eosinophilic esophagitis, express TGF-beta1, and increase esophageal smooth muscle contraction. J Allergy Clin Immunol 2010; 126:1198-204.e4.
71. Frischmeyer-Guerrerio PA, Guerrerio AL, Oswald G et al. TGFbeta receptor mutations impose a strong predisposition for human allergic disease. Sci Transl Med 2013; 5:195ra94.
72. Uh ST, Kim TH, Shim EY et al. Angiotensin-converting enzyme (ACE) gene polymorphisms are associated with idiopathic pulmonary fibrosis. Lung 2013; 191:345-51.
73. Samuel CS, Royce SG, Burton MD, Zhao C, Tregear GW, Tang ML. Relaxin plays an important role in the regulation of airway structure and function. Endocrinology 2007; 148:4259-66.
74. Mishra A. Mechanism of eosinophilic esophagitis. Immunol Allergy Clin North Am 2009; 29:29-40, viii.
75. Dellon ES, Jensen ET, Martin CF, Shaheen NJ, Kappelman MD. Prevalence of eosinophilic esophagitis in the United States. Clin Gastroenterol Hepatol 2014; 12:589.e1.